Crossmark

LDHA as a Potential Therapeutic Target for Lactylation Regulation in Spinal Cord Injury: Integrated Bioinformatics Analysis, Experimental Validation, and Drug Prediction

Crossref DOI link: https://doi.org/10.1007/s12031-025-02444-2

Published Online: 2026-01-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Bobo

Wang, Shenglong

Xu, Wenting

Su, Xiaochen

Zhang, Yulong

Lu, Ziliang

Zhang, Zhan

Zhang, Yingang
Funding

Funding for this research was provided by:

the Fundamental Research Funds for the Central Universities (No. xzy022025073)
License Information

Text and Data Mining valid from 2026-01-02

Version of Record valid from 2026-01-02
More Information

Article History

Received: 6 August 2025

Accepted: 5 November 2025

First Online: 2 January 2026

Declarations

:

: The authors declare that no Generative AI was used in the creation of this manuscript.

: All animals were housed under controlled temperature and humidity with ad libitum access to food and water. Ethical approval was obtained from the Institutional Animal Care and Use Committee of Xi’an Jiaotong University (Approval No. XJTUAE2024-05).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below